These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20665620)

  • 1. Prostate specific antigen reduction following statin therapy: Mechanism of action and review of the literature.
    Mener DJ
    IUBMB Life; 2010 Aug; 62(8):584-90. PubMed ID: 20665620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of statin medications on prostate-specific antigen levels.
    Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HMG-CoA reductase therapy on serum PSA.
    Mener DJ; Cambio A; Stoddard DG; Martin BA; Palapattu GS
    Prostate; 2010 May; 70(6):608-15. PubMed ID: 19998369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report.
    Cyrus-David MS; Weinberg A; Thompson T; Kadmon D
    J Urol; 2005 Jun; 173(6):1923-5. PubMed ID: 15879782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
    Hoque A; Chen H; Xu XC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and prostate cancer: molecular and clinical aspects.
    Papadopoulos G; Delakas D; Nakopoulou L; Kassimatis T
    Eur J Cancer; 2011 Apr; 47(6):819-30. PubMed ID: 21354784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Statins on Serum Prostate-specific Antigen Levels.
    Akduman B; Tandberg DJ; O'Donnell CI; Hughes A; Moyad MA; Crawford ED
    Urology; 2010 Nov; 76(5):1048-51. PubMed ID: 20605197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancer.
    Soto DE; Daignault S; Sandler HM; Ray ME
    Urology; 2009 Jan; 73(1):158-62. PubMed ID: 18722651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.
    Pantuck AJ; Leppert JT; Zomorodian N; Aronson W; Hong J; Barnard RJ; Seeram N; Liker H; Wang H; Elashoff R; Heber D; Aviram M; Ignarro L; Belldegrun A
    Clin Cancer Res; 2006 Jul; 12(13):4018-26. PubMed ID: 16818701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.
    Gleave ME; Goldenberg SL; Jones EC; Bruchovsky N; Sullivan LD
    J Urol; 1996 Jan; 155(1):213-9. PubMed ID: 7490838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of prostate-specific antigen in the chemoprevention of prostate cancer.
    Crawford ED; DeAntoni EP; Ross CA
    J Cell Biochem Suppl; 1996; 25():149-55. PubMed ID: 9027612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of recent evidence in support of a role for statins in the prevention of prostate cancer.
    Hamilton RJ; Freedland SJ
    Curr Opin Urol; 2008 May; 18(3):333-9. PubMed ID: 18382245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.
    Hsieh TC; Wu JM
    Int J Oncol; 2002 Mar; 20(3):583-8. PubMed ID: 11836572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.
    Gleave ME; Hsieh JT; Wu HC; von Eschenbach AC; Chung LW
    Cancer Res; 1992 Mar; 52(6):1598-605. PubMed ID: 1371718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of finasteride on prostate specific antigen: review of available data.
    Guess HA; Gormley GJ; Stoner E; Oesterling JE
    J Urol; 1996 Jan; 155(1):3-9. PubMed ID: 7490873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of prostate specific antigen testing for prostate cancer in elderly men.
    Dyche DJ; Ness J; West M; Allareddy V; Konety BR
    J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride.
    Andriole GL; Marberger M; Roehrborn CG
    J Urol; 2006 May; 175(5):1657-62. PubMed ID: 16600723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.